Rockefeller Capital Management
IMCR icon

Rockefeller Capital Management’s Immunocore IMCR Stock Holding History

Rockefeller Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254 Hold
8
– – ﹤0.01% 4643
2026
Q1 		$241 Sell
8
-1,351
-99% -$43.7K ﹤0.01% 4595
2025
Q4 		$47.2K Buy
+1,359
New +$48K ﹤0.01% 3098
2023
Q1 		– Sell
-165
Closed -$9K – 2907
2022
Q4 		$9K Buy
+165
New +$9.29K ﹤0.01% 3122
2022
Q1 		– Sell
-1,000
Closed -$34K – 3964
2021
Q4 		$34K Buy
+1,000
New +$36.2K ﹤0.01% 2383

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Rockefeller Capital Management's IMCR Position: Q2 2026 in Review

Rockefeller Capital Management held its Immunocore (IMCR) position steady in Q2 2026 at 8 shares worth $254. The position accounts for ﹤0.01% of the portfolio, ranked #4643.

Rockefeller Capital Management first reported a position in IMCR in Q4 2021 and has held it in 5 quarters since. The position peaked at $47.2K in Q4 2025. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Rockefeller Capital Management held 8 shares of Immunocore worth $254 as of Q2 2026.
  • Rockefeller Capital Management left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4643 holding.
  • Rockefeller Capital Management first reported a position in Immunocore in Q4 2021 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Immunocore position peaked at $47.2K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.